Adaptimmune Therapeutics plc (ADAP) Ownership

$0.15

north_east
$0.02 (18.99%)
Day's range
$0.13
Day's range
$0.16

Adaptimmune Therapeutics plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LONG FOCUS CAPITAL MANAGEMENT, LLC 11/14/2025 18.58 M $2.42 M   -21.80% 7.03%
UBS GROUP AG 11/13/2025 6.67 M $866.76 K   10,490.17% 2.52%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 4.05 M $527.03 K   115.32% 1.54%
MORGAN STANLEY 11/14/2025 3.67 M $476.59 K   -13.38% 1.39%
JANE STREET GROUP, LLC 11/14/2025 2.81 M $364.69 K   100.00% 1.06%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 1.49 M $186.00 K   -24.39% 0.56%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.32 M $171.56 K   15.59% 0.50%
EMPIRICAL FINANCE, LLC 11/13/2025 800.00 K $104.00 K   0.00% 0.30%
B. RILEY WEALTH ADVISORS, INC. 10/31/2025 500.00 K $65.00 K   100.00% 0.19%
RATHBONES GROUP PLC 11/13/2025 432.82 K $56.27 K   0.00% 0.16%
FMR LLC 11/13/2025 340.41 K $44.25 K   -26.68% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 308.07 K $40.05 K   637.26% 0.12%
CITADEL ADVISORS LLC 11/14/2025 143.50 K $18.66 K   100.00% 0.05%
CITADEL ADVISORS LLC 11/14/2025 137.70 K $17.90 K   100.00% 0.05%
LUMBARD & KELLNER, LLC 11/12/2025 114.26 K $14.85 K   100.00% 0.04%
LAKERIDGE WEALTH MANAGEMENT LLC 10/17/2025 110.40 K $14.35 K   100.00% 0.04%
XTX TOPCO LTD 11/14/2025 102.50 K $13.33 K   28.09% 0.04%
STATE OF TENNESSEE, TREASURY DEPARTMENT 11/14/2025 73.38 K $9.54 K   0.00% 0.03%
CAPTRUST FINANCIAL ADVISORS 11/19/2025 68.72 K $8.93 K   -13.10% 0.03%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 67.03 K $8.71 K   0.00% 0.03%
GROUP ONE TRADING, L.P. 11/12/2025 61.73 K $8.03 K   100.00% 0.02%
SEI INVESTMENTS CO 11/13/2025 54.82 K $7.13 K   0.00% 0.02%
STATE OF NEW JERSEY COMMON PENSION FUND D 11/07/2025 54.72 K $7.11 K   0.00% 0.02%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 11/14/2025 53.19 K $6.91 K   0.00% 0.02%
NORTHERN TRUST CORP 11/14/2025 48.58 K $6.32 K   -5.36% 0.02%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 10/29/2025 40.82 K $5.66 K   277.37% 0.02%
BLACKROCK, INC. 11/12/2025 38.30 K $4.98 K   -78.62% 0.01%
COLUMBIA ADVISORY PARTNERS LLC 10/24/2025 36.73 K $4.78 K   0.00% 0.01%
SIMON QUICK ADVISORS, LLC 10/21/2025 30.00 K $3.90 K   0.00% 0.01%
SG AMERICAS SECURITIES, LLC 10/23/2025 27.50 K $4.00 K   100.00% 0.01%
RAYMOND JAMES FINANCIAL INC 11/14/2025 25.26 K $3.28 K   0.00% 0.01%
PROSPERITY WEALTH MANAGEMENT, INC. 11/14/2025 19.23 K $2.50 K   -2.71% 0.01%
STONEX GROUP INC. 11/14/2025 15.04 K $1.96 K   100.00% 0.01%
TRAYNOR CAPITAL MANAGEMENT, INC. 11/03/2025 15.00 K $1.95 K   100.00% 0.01%
SIMPLEX TRADING, LLC 11/12/2025 12.42 K $1.00 K   100.00% 0.00%
GOLDMAN SACHS GROUP INC 11/14/2025 12.32 K $1.60 K   100.00% 0.00%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 11/14/2025 12.17 K $1.58 K   100.00% 0.00%
IFG ADVISORY, LLC 11/12/2025 11.73 K $1.52 K   0.00% 0.00%
X-SQUARE CAPITAL, LLC 11/10/2025 11.57 K $1.00 K   3.58% 0.00%
KORNITZER CAPITAL MANAGEMENT INC /KS 10/31/2025 10.00 K $1.30 K   0.00% 0.00%
RHUMBLINE ADVISERS 11/06/2025 5.74 K $745   -32.70% 0.00%
WELLS FARGO & COMPANY/MN 11/13/2025 2.70 K $351   -94.48% 0.00%
CITIGROUP INC 11/10/2025 2.68 K $348   100.00% 0.00%
BARCLAYS PLC 11/12/2025 2.53 K $330   0.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 2.06 K $198   -97.71% 0.00%
RAIFFEISEN BANK INTERNATIONAL AG 11/10/2025 907 $118   100.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 700 $91   -93.59% 0.00%
BRYN MAWR TRUST CO 11/20/2025 604 $79   0.00% 0.00%
HIGHMARK WEALTH MANAGEMENT LLC 10/20/2025 287 $37   0.00% 0.00%
PARALLEL ADVISORS, LLC 11/13/2025 250 $33   0.00% 0.00%

Adaptimmune Therapeutics plc institutional Ownership - FAQ's

During the previous two years, 100 institutional investors and hedge funds held shares of Adaptimmune Therapeutics plc. The most heavily invested institutionals were:

Long Focus Capital Management, LLC: 18.58 M

UBS Group AG: 6.67 M

RENAISSANCE TECHNOLOGIES LLC: 4.05 M

MORGAN STANLEY: 3.67 M

JANE STREET GROUP, LLC: 2.81 M

ACADIAN ASSET MANAGEMENT LLC: 1.49 M

15.94% of Adaptimmune Therapeutics plc stock is owned by institutional investors.

Institutional investors have bought a total of 42.71 M shares in the last 24 months. This purchase volume represents approximately $6.56 M in transactions.